{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:30:23Z","timestamp":1787509823661,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781071652176","type":"print"},{"value":"9781071652183","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5218-3_11","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:28:03Z","timestamp":1774999683000},"page":"143-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assays for Plasma ADAMTS13 Activity and Inhibitors Using Recombinant FRETS-VWF73 Peptide"],"prefix":"10.1007","author":[{"given":"Sarah H.","family":"Gralnek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szumam","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393\u2013397","journal-title":"N Engl J Med"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"41059","DOI":"10.1074\/jbc.C100515200","volume":"276","author":"X Zheng","year":"2001","unstructured":"Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059\u201341063","journal-title":"J Biol Chem"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.med.53.082901.103948","volume":"53","author":"JL Moake","year":"2002","unstructured":"Moake JL (2002) Thrombotic thrombocytopenic purpura: the systemic clumping \u201cplague\u201d. Annu Rev Med 53:75\u201388","journal-title":"Annu Rev Med"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","volume":"2","author":"MR Thomas","year":"2015","unstructured":"Thomas MR, de Groot R, Scully MA, Crawley JT (2015) Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. EBioMedicine 2:942\u2013952","journal-title":"EBioMedicine"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL (2015) ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 66:211\u2013225","journal-title":"Annu Rev Med"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488\u2013494","journal-title":"Nature"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","volume":"95","author":"XL Zheng","year":"2010","unstructured":"Zheng XL, Wu HM, Shang D, Falls E, Skipwith CG, Cataland SR et al (2010) Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica 95:1555\u20131562","journal-title":"Haematologica"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1182\/blood-2003-12-4165","volume":"103","author":"C Klaus","year":"2004","unstructured":"Klaus C, Plaimauer B, Studt JD, Dorner F, Lammle B, Mannucci PM et al (2004) Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. Blood 103:4514\u20134519","journal-title":"Blood"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/jca.21366","volume":"30","author":"B Ferrari","year":"2015","unstructured":"Ferrari B, Cairo A, Pontiggia S, Mancini I, Masini L, Peyvandi F (2015) Congenital and acquired ADAMTS13 deficiency: two mechanisms, one patient. J Clin Apher 30:252\u2013256","journal-title":"J Clin Apher"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1182\/bloodadvances.2020004172","volume":"5","author":"K Kangro","year":"2021","unstructured":"Kangro K, Roose E, Joly BS, Sinkovits G, Falter T, von Auer C et al (2021) Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood Adv 5:3427\u20133435","journal-title":"Blood Adv"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/jth.15822","volume":"20","author":"K Halkidis","year":"2022","unstructured":"Halkidis K, Zheng XL (2022) ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura. J Thromb Haemost 20:2197\u20132203","journal-title":"J Thromb Haemost"},{"key":"11_CR12","volume":"12","author":"S Bukhari","year":"2020","unstructured":"Bukhari S, Aslam HM, Awwal TA, Christmas D, Wallach SL (2020) Valacyclovir-induced thrombotic thrombocytopenic purpura. Cureus 12:e8156","journal-title":"Cureus"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1111\/jth.15006","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A et al (2020) ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 18:2486\u20132495","journal-title":"J Thromb Haemost"},{"issue":"11","key":"11_CR14","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1016\/j.jtha.2025.06.002","volume":"23","author":"XL Zheng","year":"2025","unstructured":"Zheng XL, Al-Housni Z, Cataland SR, Coppo P, Geldziler B, Germini F et al (2025) 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura. J Thromb Haemost 23(11):3711\u20133732","journal-title":"J Thromb Haemost"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00134-025-07981-3","volume":"51","author":"E Azoulay","year":"2025","unstructured":"Azoulay E, Veyradier A, Cataland S, Joly BS, Knoebl P, Zafrani L et al (2025) Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025. Intensive Care Med 51:1225","journal-title":"Intensive Care Med"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","volume":"390","author":"M Scully","year":"2024","unstructured":"Scully M, Antun A, Cataland SR, Coppo P, Dossier C, Biebuyck N et al (2024) Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura. N Engl J Med 390:1584\u20131596","journal-title":"N Engl J Med"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578\u20131584","journal-title":"N Engl J Med"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1160\/TH06-03-0166","volume":"95","author":"R Mahdian","year":"2006","unstructured":"Mahdian R, Rayes J, Girma JP, Houllier A, Obert B, Meyer D et al (2006) Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples. Thromb Haemost 95:1049\u20131051","journal-title":"Thromb Haemost"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"29428","DOI":"10.1074\/jbc.M505513200","volume":"280","author":"J Ai","year":"2005","unstructured":"Ai J, Smith P, Wang S, Zhang P, Zheng XL (2005) The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor. J Biol Chem 280:29428\u201329434","journal-title":"J Biol Chem"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/blood-2003-08-2861","volume":"103","author":"K Kokame","year":"2004","unstructured":"Kokame K, Matsumoto M, Fujimura Y, Miyata T (2004) VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 103:607\u2013612","journal-title":"Blood"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","volume":"129","author":"K Kokame","year":"2005","unstructured":"Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T (2005) FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129:93\u2013100","journal-title":"Br J Haematol"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1538-7836.2005.01767.x","volume":"4","author":"E Groot","year":"2006","unstructured":"Groot E, Hulstein JJ, Rison CN, de Groot PG, Fijnheer R (2006) FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 4:698\u2013699","journal-title":"J Thromb Haemost"},{"key":"11_CR23","first-page":"2993","volume":"141","author":"K Halkidis","year":"2023","unstructured":"Halkidis K, Meng C, Liu S, Mayne L, Siegel DL, Zheng XL (2023) Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura. Blood 141:2993\u20133005","journal-title":"Blood"},{"key":"11_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102603","volume":"8","author":"K Halkidis","year":"2024","unstructured":"Halkidis K, Meng C, Pillai VG, Shay M, Liu S, Zheng XL (2024) Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost 8:102603","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Methods in Molecular Biology","ADAMTS Proteases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5218-3_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:28:04Z","timestamp":1774999684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5218-3_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652176","9781071652183"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5218-3_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}